![Active Receptor Activator Of Nuclear Factor Kappa B Ligand (RANkL) | APA855Mu61 | Mus musculus (Mouse) CLOUD-CLONE CORP.(CCC) Active Receptor Activator Of Nuclear Factor Kappa B Ligand (RANkL) | APA855Mu61 | Mus musculus (Mouse) CLOUD-CLONE CORP.(CCC)](http://de.static.cloud-clone.com/product/pictures/APA855Mu61-201802091053357565.jpg)
Active Receptor Activator Of Nuclear Factor Kappa B Ligand (RANkL) | APA855Mu61 | Mus musculus (Mouse) CLOUD-CLONE CORP.(CCC)
![Probing ligand recognition of the opioid pan antagonist AT-076 at nociceptin, kappa, mu, and delta opioid receptors through structure-activity relationships | Scientific Reports Probing ligand recognition of the opioid pan antagonist AT-076 at nociceptin, kappa, mu, and delta opioid receptors through structure-activity relationships | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-017-13129-1/MediaObjects/41598_2017_13129_Fig1_HTML.jpg)
Probing ligand recognition of the opioid pan antagonist AT-076 at nociceptin, kappa, mu, and delta opioid receptors through structure-activity relationships | Scientific Reports
![Molecules | Free Full-Text | Development of Diphenethylamines as Selective Kappa Opioid Receptor Ligands and Their Pharmacological Activities Molecules | Free Full-Text | Development of Diphenethylamines as Selective Kappa Opioid Receptor Ligands and Their Pharmacological Activities](https://www.mdpi.com/molecules/molecules-25-05092/article_deploy/html/images/molecules-25-05092-g001.png)
Molecules | Free Full-Text | Development of Diphenethylamines as Selective Kappa Opioid Receptor Ligands and Their Pharmacological Activities
![Mouse RAN?L (Receptor Activator of Nuclear Factor Kappa B Ligand) CLIA Kit | Assay Genie | Biomol.com Mouse RAN?L (Receptor Activator of Nuclear Factor Kappa B Ligand) CLIA Kit | Assay Genie | Biomol.com](https://www.biomol.com/media/image/da/6f/5a/G-MOES00346-96.jpg)
Mouse RAN?L (Receptor Activator of Nuclear Factor Kappa B Ligand) CLIA Kit | Assay Genie | Biomol.com
![RANKL, And Activation Of Osteoclast. From Monocyte To Precursor Cell And Osteoclast. Normal And Pathological Conditions. RANKL, And Activation Of Osteoclast. From Monocyte To Precursor Cell And Osteoclast. Normal And Pathological Conditions.](https://previews.123rf.com/images/designua/designua2010/designua201000002/156366299-rankl-and-activation-of-osteoclast-from-monocyte-to-precursor-cell-and-osteoclast-normal-and-patholo.jpg)
RANKL, And Activation Of Osteoclast. From Monocyte To Precursor Cell And Osteoclast. Normal And Pathological Conditions.
![Loading history changes the morphology and compressive force-induced expression of receptor activator of nuclear factor kappa B ligand/osteoprotegerin in MLO-Y4 osteocytes [PeerJ] Loading history changes the morphology and compressive force-induced expression of receptor activator of nuclear factor kappa B ligand/osteoprotegerin in MLO-Y4 osteocytes [PeerJ]](https://dfzljdn9uc3pi.cloudfront.net/2020/10244/1/fig-1-full.png)
Loading history changes the morphology and compressive force-induced expression of receptor activator of nuclear factor kappa B ligand/osteoprotegerin in MLO-Y4 osteocytes [PeerJ]
![Switching between kappa(2) and kappa(3) bis(pyrazol-1-yl)acetate ligands by tuning reaction conditions: synthesis, spectral, electrochemical, structural, and theoretical studies on arene-Ru(II) derivatives of bis(azol-1-yl)acetate ligands. | Semantic ... Switching between kappa(2) and kappa(3) bis(pyrazol-1-yl)acetate ligands by tuning reaction conditions: synthesis, spectral, electrochemical, structural, and theoretical studies on arene-Ru(II) derivatives of bis(azol-1-yl)acetate ligands. | Semantic ...](https://d3i71xaburhd42.cloudfront.net/f8ff9e9db728d84cc02929c9e7fcae6599a8675e/8-Figure1-1.png)
Switching between kappa(2) and kappa(3) bis(pyrazol-1-yl)acetate ligands by tuning reaction conditions: synthesis, spectral, electrochemical, structural, and theoretical studies on arene-Ru(II) derivatives of bis(azol-1-yl)acetate ligands. | Semantic ...
![A Systematic Review on the Kappa Opioid Receptor and Its Ligands: New Directions for the Treatment of Pain, Anxiety, Depression, and Drug Abuse | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage A Systematic Review on the Kappa Opioid Receptor and Its Ligands: New Directions for the Treatment of Pain, Anxiety, Depression, and Drug Abuse | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage](https://chemrxiv.org/engage/api-gateway/chemrxiv/assets/orp/resource/item/62c8920a6383266dc946ad00/largeThumb/a-systematic-review-on-the-kappa-opioid-receptor-and-its-ligands-new-directions-for-the-treatment-of-pain-anxiety-depression-and-drug-abuse.jpg)
A Systematic Review on the Kappa Opioid Receptor and Its Ligands: New Directions for the Treatment of Pain, Anxiety, Depression, and Drug Abuse | Biological and Medicinal Chemistry | ChemRxiv | Cambridge Open Engage
![Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands | SpringerLink Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands | SpringerLink](https://media.springernature.com/lw685/springer-static/image/chp%3A10.1007%2F164_2020_431/MediaObjects/500126_1_En_431_Fig1_HTML.png)
Kappa Opioid Receptor Ligands and Pharmacology: Diphenethylamines, a Class of Structurally Distinct, Selective Kappa Opioid Ligands | SpringerLink
![APA855Ra61 | Active Receptor Activator Of Nuclear Factor Kappa B Ligand (RANkL) | Rattus norvegicus (Rat) USCN(Wuhan USCN Business Co., Ltd. ) APA855Ra61 | Active Receptor Activator Of Nuclear Factor Kappa B Ligand (RANkL) | Rattus norvegicus (Rat) USCN(Wuhan USCN Business Co., Ltd. )](http://static.cloud-clone.cn/product/pictures/APA855Ra61-202105071050042743.jpg)
APA855Ra61 | Active Receptor Activator Of Nuclear Factor Kappa B Ligand (RANkL) | Rattus norvegicus (Rat) USCN(Wuhan USCN Business Co., Ltd. )
![The design and synthesis of kappa opioid ligands based on a binding model for kappa agonists - ScienceDirect The design and synthesis of kappa opioid ligands based on a binding model for kappa agonists - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960894X00806770-gr1.gif)
The design and synthesis of kappa opioid ligands based on a binding model for kappa agonists - ScienceDirect
![Representative examples of common scaffolds in kappa opioid receptor... | Download Scientific Diagram Representative examples of common scaffolds in kappa opioid receptor... | Download Scientific Diagram](https://www.researchgate.net/publication/319055003/figure/fig2/AS:658264614256644@1533953922774/Representative-examples-of-common-scaffolds-in-kappa-opioid-receptor-ligands.png)